<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mercury toxicity</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mercury toxicity</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mercury toxicity</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gillian Beauchamp, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shana Kusin, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carl-Gustaf Elinder, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gary C Curhan, MD, ScD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 24, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Mercury exists in elemental, inorganic, and organic forms, all of which may be toxic [<a href="#rid1">1-4</a>]. The toxic manifestation depends on the form of exposure. This topic reviews sources of mercury exposure, the clinical manifestations, and the treatment and prevention of mercury toxicity.</p><p>Potential toxicity from ingestion of fish during pregnancy is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/431.html" rel="external">"Fish consumption and marine omega-3 fatty acid supplementation in pregnancy"</a> and  <a class="medical medical_review" href="/z/d/html/130920.html" rel="external">"Nutrition in pregnancy: Assessment and counseling", section on 'Guidelines for safe seafood consumption'</a>.)</p><p>The use of thimerosal in vaccines is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2861.html" rel="external">"Autism spectrum disorder and chronic disease: No evidence for vaccines or thimerosal as a contributing factor"</a>.)</p><p class="headingAnchor" id="H3444329540"><span class="h1">ELEMENTAL MERCURY TOXICITY</span><span class="headingEndMark"> — </span>Elemental mercury is a silver-colored liquid ("quicksilver") that is volatile at room temperature and causes pulmonary and neurologic toxicity, as well as nephrotoxicity in severe or prolonged exposures [<a href="#rid5">5</a>]. Elemental mercury forms a vapor at room temperature, and the major route of absorption is through the lungs [<a href="#rid6">6</a>]. Elemental mercury is poorly absorbed via the gastrointestinal tract or skin [<a href="#rid6">6</a>]. Although a small fraction of the mercury vapor taken into the lung is eliminated via exhalation, most absorbed mercury is eliminated in the feces [<a href="#rid7">7,8</a>].</p><p>The central nervous system is the major site of deposition for mercury derived from inhalation exposure of vapor.</p><p class="headingAnchor" id="H2027445987"><span class="h2">Sources of exposure</span><span class="headingEndMark"> — </span>Potential occupational sources of exposure to elemental mercury include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Manufacturing processes</strong> – Mercury is still used in the manufacture of some instruments, including sphygmomanometers, manometers, thermometers, and barometers, although non-mercury based forms of these devices are more common [<a href="#rid9">9,10</a>]. Mercury is also contained in compact fluorescent light bulbs. Mercury toxicity may result from inhalation of mercury vapor during the manufacturing or recycling of such bulbs [<a href="#rid11">11-13</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Artisanal gold mining</strong> – Liquid elemental mercury can be used to concentrate gold from crushed ore or sediments. While mercury was historically used throughout the world to extract gold from ore [<a href="#rid14">14,15</a>], more efficient processes are now used in large-scale industrial mining. In over 70 developing nations, mercury toxicity remains a concern among artisanal and often illegal small-scale mining practices, which involve over 10 million workers [<a href="#rid16">16</a>], and a growing practice of recreational home gold extraction in the United States has led to case reports of toxicity [<a href="#rid17">17</a>]. More recently, a patient developed acute mercury toxicity from using elemental mercury to recover gold and silver from computer components [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dentistry</strong> – Amalgam tooth fillings are widely used in dentistry around the world. Amalgam, or dental silver, is an alloy of 50 percent metallic mercury and 50 percent metal powder (which is usually composed of silver, tin, copper, and zinc in certain proportions) [<a href="#rid3">3</a>]. A small amount of elemental mercury is released from amalgam fillings. The magnitude of release is proportional to the number of fillings and the total amalgam surface area. Individuals who habitually grind their teeth release more mercury from their dental fillings than those who do not [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1">Amalgam fillings are not believed to cause mercury toxicity. An expert committee from the World Health Organization believes that the average exposure from dental amalgam is approximately 10 mcg/day, well below toxic levels [<a href="#rid6">6</a>]. The exposure to mercury vapor from dental amalgams is usually far less than mercury exposure from foods such as predatory fish. (See <a class="local">'Sources of exposure'</a> below.)</p><p></p><p class="bulletIndent1">According to the US Department of Health and Human Services Agency for Toxic Substances and Disease Registry, exposure to mercury from dental amalgams is less than 1 percent of the daily vapor dose that is considered to be safe in the occupational setting [<a href="#rid20">20</a>]. Although some small studies have suggested that chronic occupational exposure to these low levels by dental workers may cause subtle neuropsychiatric effects [<a href="#rid21">21,22</a>], studies have not correlated any symptoms or clinically significant health effects with absorption from dental amalgams [<a href="#rid7">7,23-28</a>].</p><p></p><p class="bulletIndent1">There is little or no evidence to support the removal of existing fillings [<a href="#rid7">7</a>].</p><p></p><p>Other sources include chloralkali industries, gold gilders, metal refineries, skin-lightening cosmetics, deposition from coal-fueled power plants, and cement production [<a href="#rid29">29-32</a>].</p><p class="headingAnchor" id="H1667904223"><span class="h3">Decreasing exposure</span><span class="headingEndMark"> — </span>Exposure to mercury has significantly lessened during recent years because of increased attention to minimizing exposure. Previously, gold and silver miners and chloralkali industrial workers commonly encountered air concentrations of mercury in excess of the Occupational Health and Safety Administration (OSHA) permissible exposure limit (PEL) of 100 mcg/m<sup>3</sup> during an eight-hour work day, with air concentrations reported as high at 500 mcg/m<sup>3</sup> in connection with some mining operations [<a href="#rid33">33</a>]. Clinically significant health effects including neuropsychological abnormalities, pulmonary toxicity, and kidney dysfunction were common at such exposures [<a href="#rid34">34,35</a>]. The occupational threshold limit value (TLV) has been lowered to 50 mcg/m<sup>3</sup> or less in most countries. The Federal OSHA in the United States has set a mercury PEL of 100 mcg/m<sup>3</sup> (eight-hour time-weighted average [TWA]), but some state OSHA programs regulate a stricter limit at 50 mcg/m<sup>3</sup> (eight-hour TWA) [<a href="#rid36">36</a>]. Despite these regulations, small-scale artisanal miners around the world remain at risk of mercury toxicity due to lack of regulations in often illegal mining operations [<a href="#rid16">16</a>].</p><p>Measurements of mercury in blood and urine are useful in quantifying the degree of exposure [<a href="#rid4">4</a>]. (See <a class="local">'Diagnosis'</a> below.)</p><p>There is a linear relationship between air and urine concentrations of mercury in most situations. The urine concentration (in mcg/L) corresponds to air concentration (in mcg/m<sup>3</sup>) multiplied by 1 to 2 [<a href="#rid37">37</a>].</p><p>Exposure to mercury vapor has also declined in dentistry, where ambient mercury concentrations between 1960 and 1970 were frequently approximately 25 mcg/m<sup>3</sup>; present values are below 5 mcg/m<sup>3</sup> due to improved ventilation and handling of amalgam. Dental amalgam is still used in dentistry, although use is declining due to unfounded concerns from the public regarding mercury toxicity. Health problems associated with exposure due to mercury in dental amalgams have only been reported in dental workers with persistent high concentration exposures due to poor workplace ventilation, resulting in fatigue, generalized weakness, and anorexia [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H3948028983"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>The predominant clinical manifestations of toxicity from exposure to elemental mercury vapor depend on the acuity and severity of exposure.</p><p class="headingAnchor" id="H3028663512"><span class="h3">Acute</span><span class="headingEndMark"> — </span>A severe and potentially fatal interstitial pneumonitis may result when mercury vapor is inhaled at concentrations greater than 1000 mcg/m<sup>3</sup>. Individuals at risk for toxicity due to inhaled mercury include those who work in settings involved in either manufacture or recycling of products containing mercury such as fluorescent bulbs, thermometers, manometers, barometers, valves, batteries, and switches [<a href="#rid39">39</a>]. A worker with a concerning occupational history presenting with the symptoms described below should be evaluated for acute mercury toxicity [<a href="#rid6">6,18,40-44</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Cough, dyspnea, and chest pain</p><p class="bulletIndent1"><span class="glyph">●</span>Stomatitis, inflammation of the gums, and excessive salivation</p><p class="bulletIndent1"><span class="glyph">●</span>Severe nausea, vomiting, and diarrhea, which can lead to shock</p><p class="bulletIndent1"><span class="glyph">●</span>Conjunctivitis and dermatitis</p><p></p><p>A variety of the above signs and symptoms may also occur after acute exposure to lower air concentrations of mercury in the range of 100 to 1000 mcg/m<sup>3</sup>.</p><p class="headingAnchor" id="H46498975"><span class="h3">Chronic</span><span class="headingEndMark"> — </span>Chronic exposure to lower concentrations of elemental mercury vapors results in predominantly nervous system effects. Mild neuropsychiatric symptoms such as tremor and insomnia may occur due to chronic exposure to mercury vapors at concentrations as low as 25 mcg/m<sup>3</sup> [<a href="#rid6">6</a>]. While symptoms typically remain mild below the OSHA PEL of 100 mcg/m<sup>3</sup>, higher concentrations may lead to severe symptoms, such as intention tremors of the fingers and hands that make handwriting difficult. A hallmark of mercury poisoning is erethism or <em>erethismus mercurialis</em>, historically known as Mad Hatter syndrome, features of which include a change in personality, anxiety, irritability, excitability, fearfulness, pathologic shyness, insomnia, memory loss, depression, fatigue, weakness, and drowsiness [<a href="#rid4">4,6,34,35,41</a>]. Other symptoms may include diaphoresis, a desquamating rash, and hair loss.</p><p>Even more subtle central nervous system effects may also occur. The early effects of mercury exposure have been studied in occupational health studies [<a href="#rid7">7</a>]. Several studies have shown a dose-response relationship between subjective symptoms and/or impaired performance on psychologic tests [<a href="#rid34">34,35,45</a>]. </p><p>As with higher exposures, the chronically exposed patient may also describe tender and inflamed gums, excessive salivation, and swollen salivary glands.</p><p>In severe cases, permanent central nervous system impairment may result [<a href="#rid4">4,6,41,46</a>]. Fetal toxicity from methylmercury from maternal seafood ingestion has resulted in irreversible brain damage but is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/111468.html" rel="external">"Occupational and environmental risks to reproduction in females: Specific exposures and impact", section on 'Reproductive health impact'</a>.)</p><p>Cases of nephrotic syndrome (usually with organic mercury salts) related to chronic occupational exposure to elemental mercury have been reported. Two cases of membranous nephropathy were reported from a fluorescent-tube recycling industry in Germany [<a href="#rid47">47</a>]. Heavy occupational exposure to mercury was evident from markedly elevated urinary excretion of mercury (118 and 158 mcg Hg/L, respectively). Two years after withdrawal from exposure to mercury, urinary excretion of mercury and protein was almost normal in one patient. The second patient was treated but lost to follow-up. Membranous nephropathy has also been reported among two members of the same family due to inadvertent residential exposure to mercury [<a href="#rid48">48</a>]. Membranous nephropathy from mercury toxicity was seen in a 14-year-old male with previous reflux nephropathy [<a href="#rid48">48</a>]. The boy lived in a small trailer home where fluid metallic mercury had been spilled on counter tops, under the floor tiles, and on the carpet. The boy's blood mercury level was 41 mcg Hg/L and 24-hour urine mercury level 43 mcg Hg/24 hours. </p><p>A Chinese poisoning treatment center reported data on nearly 300 patients with chronic mercury poisoning, mainly due to occupational exposure and inappropriate use of mercury-containing cosmetics [<a href="#rid49">49</a>]. The most common manifestations were neurologic (50 percent), though a substantial proportion of patients (14 percent) had nephrotic-range proteinuria, most commonly secondary to membranous nephropathy.</p><p>Occupation exposure to elemental mercury has been associated with renal tubular abnormalities. (See <a class="local">'Tubular dysfunction'</a> below.) </p><p>A worker with an occupational history concerning for risk of chronic mercury toxicity who presents with neuropsychiatric symptoms, rash, diaphoresis, salivation, or gingivitis should be evaluated for chronic mercury toxicity [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H1393687342"><span class="h3">Acrodynia</span><span class="headingEndMark"> — </span>Acrodynia ("pink disease") is a specific syndrome that has been reported in small children after exposure to elemental mercury, inorganic salts, and organic phenylmercury compounds, which have been used historically in both indoor and outdoor paints [<a href="#rid50">50</a>]. Acrodynia is characterized by a body rash, extremity edema, and irritation of palms and soles, followed by skin desquamation, irritability, photophobia, fever, insomnia, and profuse sweating [<a href="#rid4">4,51,52</a>]. </p><p>Acrodynia was common among infants in the United Kingdom and the United States until the late 1940s, when it was realized that the condition was primarily caused by exposure to calomel (mercurous chloride, an inorganic mercury salt) in teething powders and in anthelminthic preparations [<a href="#rid53">53</a>]. Thought to be a hypersensitivity reaction to mercury influenced by a highly variable individual susceptibility, acrodynia affected almost exclusively infants and small children. The syndrome develops in only a small proportion of those who are exposed (&lt;1 percent) [<a href="#rid51">51</a>].</p><p>While cases of acrodynia have been historically due to chronic topical exposure to teething or antihelminthic agents, more recent reports have been secondary to respiratory exposure over weeks to months to spilled elemental mercury (ie, from broken sphygmomanometers or vials of "quicksilver") [<a href="#rid54">54,55</a>].</p><p class="headingAnchor" id="H3541308736"><span class="h3">Tubular dysfunction</span><span class="headingEndMark"> — </span>Occupational exposure to both elemental mercury vapor and inorganic mercury has been associated with subtle abnormalities in kidney tubular function. One study found a slightly higher prevalence of elevated urinary excretion of albumin, transferrin, retinol-binding protein, and the tubular enzyme, beta-galactosidase, in chloralkali workers with a urinary excretion of mercury exceeding 50 mcg/g creatinine [<a href="#rid56">56</a>].</p><p>These changes presumably reflected tubular injury, leading to the excretion of smaller proteins that are normally filtered and then largely reabsorbed. The tubular lesions are probably dose related (with large doses [grams] causing acute tubular necrosis) [<a href="#rid6">6</a>].</p><p>Analysis of the tubular enzyme N-acetyl-beta-D-glucosaminidase (NAG) may provide early evidence of nephrotoxicity from mercury [<a href="#rid57">57-60</a>]. In a thorough cross-sectional examination of chloralkali workers exposed to mercury at air concentrations of approximately 25 mcg/m<sup>3</sup>, a significant correlation and dose-response relationship were observed between the urinary excretion of mercury and NAG [<a href="#rid59">59</a>]. No significant differences were observed between exposed and control patients with respect to other kidney parameters, including urinary excretion of albumin, orosomucoid, beta2-microglobulin, or copper, or in the serum creatinine concentration.</p><p>The more subtle, tubular effects from mercury may be reversible. As an example, nephrotoxicity was not observed after extensive examination among workers who were exposed to relatively low levels of mercury an average of six years prior [<a href="#rid61">61</a>].</p><p class="headingAnchor" id="H1252387243"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of elemental mercury toxicity should be suspected among individuals who present with consistent clinical manifestations and who have a history of exposure risk via occupation such as artisanal mining [<a href="#rid16">16</a>] or smelting [<a href="#rid18">18</a>], work with fluorescent bulbs or other mercury-containing products [<a href="#rid39">39</a>], or have days to weeks of exposure to elemental mercury via a broken mercury-containing device or other mercury spill [<a href="#rid54">54,55</a>].</p><p>The diagnosis is confirmed by measuring mercury in blood and/or 24-hour urine. The preferred test depends on whether the patient is suspected of having acute or chronic mercury exposure. Whole-blood mercury should be measured in the unstable patient who has suspected acute toxicity. However, 24-hour urine mercury measurement is the preferred test to assess toxicity in patients who have suspected stable and chronic exposure to elemental mercury. While whole-blood mercury concentrations can accurately reflect a very large, acute mercury exposure, this test becomes less reliable as redistribution to tissues takes place, making 24-hour urine testing more reliable in stable, chronic, or low-grade mercury exposures.</p><p class="headingAnchor" id="H3721913315"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>All patients with toxicity from elemental mercury should be immediately removed from the source of mercury exposure. Supportive care should be provided and a whole-blood mercury level and 24-hour urine sent for measurement of mercury concentration to determine if chelation is needed [<a href="#rid5">5</a>]. For patients with suspected chronic mercury exposure, 24-hour urine mercury is used to determine if chelation is indicated. For unstable patients with acute, severe toxicity, rapid assessment for mercury toxicity can be performed using blood mercury testing as rapid testing will facilitate early chelation. Other measures depend on the form and severity of exposure  (<a class="graphic graphic_algorithm graphicRef105829" href="/z/d/graphic/105829.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H3367078138"><span class="h3">General measures and supportive care</span><span class="headingEndMark"> — </span>Patients with acute elemental mercury vapor exposure by inhalation who present with respiratory symptoms should receive supportive care including supplemental oxygen, bronchodilators, and imaging to evaluate for pneumonitis or pulmonary edema. (See  <a class="medical medical_review" href="/z/d/html/7024.html" rel="external">"Aspiration pneumonia in adults", section on 'Treatment'</a>.)</p><p>Patients with acute elemental mercury vapor exposure who have gastrointestinal symptoms should receive fluid resuscitation and monitoring for electrolyte abnormalities or kidney injury from fluid and electrolyte losses.</p><p>Patients with symptoms who have 24-hour urine testing with concentration of 100 mcg/L or greater should receive chelation treatment. As noted above, in an unstable patient with suspected acute toxicity, a whole-blood level may be used to determine whether chelation is required. (See <a class="local">'Chelator treatment'</a> below.)</p><p>Patients with oral elemental mercury exposure generally do not require specific treatment, since gastrointestinal absorption of elemental mercury is negligible. (See <a class="local">'Sources of exposure'</a> above.)</p><p class="headingAnchor" id="H2495443114"><span class="h3">Chelator treatment</span><span class="headingEndMark"> — </span>Treatment with a chelating agent is indicated in selected patients. We treat patients with known or suspected elemental mercury exposure who have a 24-hour urine concentration (or, in the patient with suspected acute toxicity, a whole-blood mercury concentration) of 100 mcg/L or greater and who have symptoms that are attributed to mercury exposure. Clinical signs and symptoms from acute poisoning of mercury are unlikely if blood and urine concentrations are &lt;100 mcg/L, although subclinical toxicity may occur below this level.</p><p>Chelators increase the urinary excretion of mercury [<a href="#rid34">34</a>]. Several studies and case reports of patients with symptomatic mercury toxicity accompanied by elevated urine mercury concentrations have shown clinical improvement after chelation therapy [<a href="#rid62">62-64</a>]. Chelation is recommended by the World Health Organization for patients with severe mercury toxicity [<a href="#rid37">37</a>].</p><p>The agents available to treat mercury poisoning are thiol-based chelating agents including <a class="drug drug_general" data-topicid="9367" href="/z/d/drug information/9367.html" rel="external">dimercaprol</a> (British anti-Lewisite [BAL]), <a class="drug drug_general" data-topicid="9747" href="/z/d/drug information/9747.html" rel="external">penicillamine</a>, unithiol (2,3 dimercaptopropane-1-sulfonate [DMPS]), and succimer (<a class="drug drug_general" data-topicid="9102" href="/z/d/drug information/9102.html" rel="external">dimercaptosuccinic acid</a> [DMSA]) [<a href="#rid4">4,34,65</a>]. The preferred agents are DMSA (if in the United States) or DMPS (if outside the United States). All of the studies of efficacy of chelating agents have used DMPS [<a href="#rid62">62-64</a>]. DMPS is not available in the United States; DMSA is believed to be equivalent to DMPS.</p><p class="bulletIndent1"><span class="glyph">●</span>If DMSA is used, a preferred regimen is 10 mg/kg orally three times daily for five days, then twice daily for 14 days. If patients are unable to tolerate oral intake, <a class="drug drug_general" data-topicid="9367" href="/z/d/drug information/9367.html" rel="external">dimercaprol</a> (BAL) may be used. Dimercaprol (BAL) is administered by deep intramuscular (IM) injection, 5 mg/kg/dose every four hours for 48 hours, then 2.5 mg/kg/dose every six hours for 48 hours, then 2.5 mg/kg/dose every 12 hours for seven days [<a href="#rid5">5</a>]. Patients initially treated with BAL who subsequently tolerate oral intake may be transitioned to DMSA treatment as tolerated [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If DMPS is used, a preferred regimen is 250 mg IM or intravenous (IV) every four hours on day 1, 250 mg IM or IV every six hours on day 2, and 250 mg IM or IV every six to eight hours for days 3 to 5.</p><p></p><p><a class="drug drug_general" data-topicid="9747" href="/z/d/drug information/9747.html" rel="external">Penicillamine</a> is rarely used because of significant gastrointestinal side effects, as well as a risk of thrombocytopenia and leukopenia [<a href="#rid5">5</a>]. However, penicillamine may be given at doses of 500 mg orally every six hours for five days, often in combination with <a class="drug drug_general" data-topicid="9839" href="/z/d/drug information/9839.html" rel="external">pyridoxine</a> (vitamin B6) in doses of 10 to 25 mg/day.</p><p>The efficacy of chelation therapy should be monitored by repeated clinical assessment and by measurement of mercury in 24-hour urine to ensure urine concentrations are approaching background levels of 20 mcg/L or lower [<a href="#rid5">5,50</a>].</p><p>Treatment may be required for a greater duration of time in severe cases of mercury poisoning.</p><p class="headingAnchor" id="H3040545882"><span class="h2">Prognosis</span><span class="headingEndMark"> — </span>Most of the pulmonary and kidney manifestations of mercury toxicity resolve after exposure has ceased. Likewise, some recovery occurs in most cases of elemental mercury neurotoxicity, but the extent of such recoveries varied considerably by individual and endpoint [<a href="#rid66">66</a>].</p><p class="headingAnchor" id="H3229327478"><span class="h1">INORGANIC MERCURY SALTS TOXICITY</span><span class="headingEndMark"> — </span>Inorganic mercury is present in various oxidation states as mercuric salts, which, if ingested, can cause severe gastroenteritis, shock, and kidney failure [<a href="#rid67">67-70</a>]. Exposure to inorganic mercury (ie, mercury salts) occurs via ingestion or from absorption across skin or mucosa [<a href="#rid53">53</a>]. Gastrointestinal absorption of both Hg<sup>+1</sup> and Hg<sup>+2</sup> is approximately 10 to 15 percent. The kidney is the major site of deposition for mercury derived from inorganic mercury compounds [<a href="#rid5">5,71</a>].</p><p class="headingAnchor" id="H375507267"><span class="h2">Sources of exposure</span><span class="headingEndMark"> — </span>Exposure to inorganic mercury may occur in chloralkali industries, industries that use electroplating, or via exposure to laboratory reagents. Exposure may also occur via ingestion of mercury-containing oral or topical medications [<a href="#rid72">72-76</a>].</p><p>Historically, inorganic mercury was used for the treatment of syphilis, psoriasis, and as a potent diuretic for congestive heart failure [<a href="#rid77">77-79</a>]. Mercury-containing compounds are still used in vaccines, antiseptics, Chinese traditional medicines, and skin-lightening creams or hair dyes [<a href="#rid1">1-3,80</a>], although these compounds have markedly different safety profiles.</p><p class="headingAnchor" id="H644472486"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>The manifestations of toxicity from inorganic mercury vary depending on acuity and severity of exposure.</p><p class="headingAnchor" id="H669071942"><span class="h3">Acute</span><span class="headingEndMark"> — </span>The acute ingestion of mercury salts may cause severe abdominal pain, accompanied by hemorrhagic gastroenteritis and associated severe volume depletion within several hours of ingestion. Ultimately, death may occur from cardiovascular collapse and shock. Patients who survive the acute insult may develop acute kidney injury related to acute tubular necrosis [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H2713372549"><span class="h3">Chronic</span><span class="headingEndMark"> — </span>Chronic exposure to lower concentrations of inorganic mercury salts causes irritability, colitis, gingivitis, stomatitis, excessive salivation, and nephrotic syndrome with varying pathologic features. Much of our knowledge of the effects of chronic exposure is from case reports of patients who were treated with mercury-containing oral or topical medications, including mercury-containing diuretics [<a href="#rid68">68-70,81-85</a>] and other medications [<a href="#rid72">72,83,86-91</a>].</p><p>Glomerular lesions causing nephrotic syndrome have been associated with mercury exposure [<a href="#rid80">80,87,89-91</a>]. In most reports, the nephrotic syndrome remitted after withdrawal of mercury compounds or treatment with a chelating agent [<a href="#rid73">73,74,83,87</a>].</p><p>Most cases of inorganic mercury-related nephrotic syndrome are due to membranous nephropathy [<a href="#rid72">72,75,80,81,83</a>]. However, minimal change disease also has been reported [<a href="#rid75">75,76,88,92</a>]. In a review of 25 individuals with mercury-associated nephrotic-range proteinuria, kidney biopsy showed membranous glomerulonephritis in 15 and minimal change disease in 4 [<a href="#rid75">75</a>]. In a case series from China, none of 13 patients with membranous nephropathy in the setting of long-term mercury exposure had evidence of phospholipase A2 receptor (PLA2R)-associated disease [<a href="#rid92">92</a>].</p><p>In addition to nephrotic syndrome, exposure to inorganic mercury salts has been associated with renal tubular abnormalities. (See <a class="local">'Tubular dysfunction'</a> above.)</p><p class="headingAnchor" id="H1309218580"><span class="h3">Acrodynia</span><span class="headingEndMark"> — </span>Acrodynia ("pink disease") is a specific syndrome that has been reported in small children after exposure to elemental mercury, inorganic salts, and organic phenylmercury compounds.<strong> </strong>(See <a class="local">'Acrodynia'</a> above.)</p><p class="headingAnchor" id="H2023591069"><span class="h3">Tubular dysfunction</span><span class="headingEndMark"> — </span>As with<strong> </strong>exposure to elemental mercury vapor, exposure to inorganic mercury has been associated with subtle abnormalities in kidney tubular function.<strong> </strong>(See <a class="local">'Tubular dysfunction'</a> above.)</p><p class="headingAnchor" id="H4176972006"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of mercury toxicity from inorganic mercury exposure should be suspected in patients who have consistent clinical features and have a history of exposure to mercury. A careful review of medications and over-the-counter products, including cosmetics or remedies purchased outside of the United States, may reveal a source of mercury exposure.</p><p>The diagnosis is confirmed by measuring mercury in blood and/or 24-hour urine. The preferred test depends on whether the patient is suspected of having acute or chronic mercury exposure. Whole-blood mercury should be measured in the unstable patient who has suspected acute toxicity. However, 24-hour urine mercury measurement is the preferred test to assess toxicity in patients who have suspected stable and chronic exposure to mercury. While whole-blood mercury concentrations can reflect very large acute mercury exposure, this test becomes less reliable as redistribution to tissues takes place, making 24-hour urine testing more reliable in stable, chronic, or low-grade mercury exposures.</p><p class="headingAnchor" id="H841053892"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>All patients with toxicity from exposure to inorganic mercury should have all potential sources of mercury exposure removed. Supportive care should be provided and a 24-hour urine sent for measurement of mercury concentration [<a href="#rid5">5</a>]. Other measures depend on the form and severity of exposure  (<a class="graphic graphic_algorithm graphicRef105829" href="/z/d/graphic/105829.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H4224839210"><span class="h3">General measures and supportive care</span><span class="headingEndMark"> — </span>Patients with inorganic mercury ingestion require aggressive fluid resuscitation, given the high risk of severe gastrointestinal symptoms leading to shock and acute kidney injury. All patients should be followed closely for electrolyte abnormalities or kidney injury from fluid and electrolyte losses.</p><p>Patients who have symptoms consistent with mercury poisoning and have either whole blood (for patients with suspected acute toxicity) or 24-hour urine testing (for patients with suspected chronic toxicity) with a concentration of 100 mcg/L or greater should receive chelation treatment. (See <a class="local">'Chelation treatment'</a> below.)</p><p class="headingAnchor" id="H4101427896"><span class="h3">Chelation treatment</span><span class="headingEndMark"> — </span>We chelate patients with known or suspected inorganic mercury salt ingestion exposure who have 24-hour urine or whole-blood concentration of 100 mcg/L or greater and who have symptoms that are attributed to mercury exposure. Clinical signs and symptoms from acute poisoning of mercury are unlikely if blood and urine concentrations are &lt;100 mcg/L, although subclinical toxicity may occur below this level. The preferred agent and dose are the same as for elemental mercury toxicity. (See <a class="local">'Chelator treatment'</a> above.)</p><p>The efficacy of chelation therapy should be monitored by repeated clinical assessment and by measurement of mercury in 24-hour urine to ensure urine concentrations are approaching background levels of 20 mcg/L or lower [<a href="#rid5">5,50</a>].</p><p>Treatment may be required for a greater duration of time in severe cases of mercury poisoning.</p><p class="headingAnchor" id="H4158937623"><span class="h3">Kidney toxicity</span><span class="headingEndMark"> — </span>No specific treatment is recommended for chronic kidney toxicity from mercury in the otherwise asymptomatic patient. The most important action is to eliminate or minimize exposure to mercury as nephrotic syndrome due to mercury is usually reversible, although it may take several months [<a href="#rid90">90,91</a>].</p><p>Patients who have kidney toxicity resulting from an acute exposure to mercury may have an indication for chelation treatment. (See <a class="local">'Chelator treatment'</a> above.)</p><p>While hemodialysis may become necessary in cases of severe kidney failure due to mercury toxicity, the efficacy of hemodialysis for removal of the mercury moiety itself is limited by its large volume of distribution and significant protein binding [<a href="#rid67">67</a>].</p><p class="headingAnchor" id="H1063299940"><span class="h1">ORGANIC MERCURY TOXICITY</span><span class="headingEndMark"> — </span>The ingestion of organic mercury as part of organomercuric compounds causes severe neurologic toxicity [<a href="#rid6">6,7,93,94</a>]. Alkyl mercurials such as methylmercury are efficiently absorbed from the gastrointestinal tract. Organic mercury compounds are lipophilic. The lipophilicity facilitates distribution to the central nervous system and passage across the placenta [<a href="#rid95">95</a>]. The kidney, liver, hair, and central nervous system are major sites of deposition [<a href="#rid96">96</a>].</p><p>Organic mercury compounds are defined by their bound hydrocarbon moieties. Among these compounds, dimethylmercury is particularly toxic [<a href="#rid97">97,98</a>]. In one case report, accidental dermal exposure to approximately 1.3 g of dimethylmercury (contained in approximately 0.44 mL) resulted in severe delayed neurotoxicity and death despite aggressive treatment [<a href="#rid97">97</a>].</p><p>Chronic consumption of organic mercury compounds has caused severe epidemics of poisoning in Japan and Iraq [<a href="#rid4">4,6,99-101</a>].</p><p class="headingAnchor" id="H826480880"><span class="h2">Sources of exposure</span><span class="headingEndMark"> — </span>Exposure to organic mercury is mostly via consumption of mercury-contaminated fish. Concerns of a potential health risk resulting from exposure to thimerosal, which is a preservative used in some vaccines that releases ethylmercury, have been raised by the lay public. However, there is no evidence to suggest that exposure to thimerosal causes pediatric neurodevelopmental disorders [<a href="#rid102">102-104</a>]. While controversy surrounding mercury exposure led to the reduction in its use in American vaccinations, thimerosal is still used as a pharmaceutical preservative in other nations [<a href="#rid105">105</a>]. This issue is further discussed in separate topic reviews. (See  <a class="medical medical_review" href="/z/d/html/2074.html" rel="external">"Allergic reactions to vaccines", section on 'Thimerosal, aluminum, and phenoxyethanol'</a> and  <a class="medical medical_review" href="/z/d/html/2861.html" rel="external">"Autism spectrum disorder and chronic disease: No evidence for vaccines or thimerosal as a contributing factor"</a>.)</p><p>Potential occupational exposures to organic mercury also include wood preservation and outdoor painting.</p><p>The concentration of mercury is very low in most food (&lt;0.02 mg/kg). However, certain types of marine fish (such as shark, swordfish, and tuna) and certain fish taken from polluted fresh waters (such as pike, walleye, and bass) may contain high concentrations of mercury, almost completely in the form of methylmercury. According to the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Fmetals-and-your-food%2Fmercury-concentrations-fish-fda-monitoring-program-1990-2010&amp;token=IrJx1vH5NL1IRyJXjLJSPwIHl27u2fntbTdKYgcllmF6syqSQPIQJdK%2FJkC2ycwuzX7Xppew5U2MmkoVkiMm3dZMVgrpoBG3h4A31A5AL6yIMi6EpZvWUCyFoLwCg3lS&amp;TOPIC_ID=7179" target="_blank">US Food and Drug Administration Monitoring Program 1990 to 2010</a>, concentrations of methylmercury in these fish may be 1 mg/kg (1 ppm) or even higher. A concentration of more than 0.5 mg/kg (0.5 ppm) is considered very high. Epidemics of severe neurologic disease were caused by the consumption of food contaminated with methylmercury in Minamata, Japan, in the 1940s and in Iraq in 1971 [<a href="#rid99">99-101,106</a>].</p><p>According to the Natural Resources Defense Council, fish with 0.3 to 0.49 mg/kg (0.3 to 0.49 ppm) may be safely consumed three times per month. Fish with &gt;0.5 mg/kg should be avoided. The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.epa.gov%2Fmercury%2Fwhat-epa-doing-reduce-mercury-pollution-and-exposures-mercury&amp;token=3yNBZk9TQfJBcta3Hr1mPoO14eTYPxeSpg7s%2FQh%2FKFeystugsLUIKk5Snt77DLHzbfNZVaJOxPCRqpxO9B1xOje4lb%2FwIsG5fKSLPjW6QtY%3D&amp;TOPIC_ID=7179" target="_blank">Environmental Protection Agency</a> recommends a maximum daily exposure to mercury of 0.1 mcg/kg of body weight, which will typically result in a blood mercury concentration of less than 6 mcg/L.</p><p>Monitoring of mercury in blood or urine may be used to identify and quantify exposure to methylmercury [<a href="#rid37">37</a>]. Heavy consumers of fish and, in particular, those who eat species such as swordfish or shark may have blood mercury levels more than 20 mcg/L (normal value &lt;5 mcg/L). While adult patients with excessive organic mercury consumption may present with subtle neurocognitive effects such as mild deficits in fine motor, verbal memory, and attention, effects in children exposed as fetuses may be more severe [<a href="#rid107">107</a>]. </p><p>Recommended dietary allowances for children and fetuses (via the mother) are lower [<a href="#rid108">108</a>]. (See  <a class="medical medical_review" href="/z/d/html/130920.html" rel="external">"Nutrition in pregnancy: Assessment and counseling", section on 'Guidelines for safe seafood consumption'</a>.)</p><p class="headingAnchor" id="H4166022210"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>Significant<strong> </strong>organic mercury exposure causes acute gastrointestinal and respiratory symptoms, followed by neurologic symptoms that include paresthesias (notably around the mouth), malaise, constriction of the visual field, deafness, and ataxia [<a href="#rid94">94</a>]. The fetus is particularly vulnerable. </p><p class="headingAnchor" id="H1744826898"><span class="h3">Acrodynia</span><span class="headingEndMark"> — </span>Acrodynia ("pink disease") is a specific syndrome that has been reported in small children after exposure to elemental mercury, inorganic salts, and organic phenylmercury compounds.<strong> </strong>(See <a class="local">'Acrodynia'</a> above.)</p><p class="headingAnchor" id="H1917284753"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of organic mercury toxicity should be suspected among individuals who present with consistent clinical manifestations and who have a history of ingestion of potentially contaminated fish or the rare case of occupational exposure. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>In contrast to testing for elemental or inorganic mercury toxicity, the preferred test for determining toxicity from organic mercury is a whole-blood mercury level. Organic mercury is eliminated via the fecal route, rendering urine mercury testing less useful in organic mercury poisoning.</p><p>Mercury should not be measured in hair. Because mercury accumulates in the hair, hair analysis was previously used to measure mercury burden in chronic exposure. However, hair avidly binds to noningested environmental mercury, and metal incorporation into hair reflects only past exposure. As such, the reliability of this method for informing clinical management is questionable and is not recommended by toxicologists.</p><p class="headingAnchor" id="H15"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>All patients with potential organic mercury toxicity should cease all exposure to organic mercury. A 24-hour urine should be sent for measurement of mercury concentration [<a href="#rid5">5</a>].There is no<strong> </strong>effective treatment for patients with toxic exposure to organic mercury. Neurologic damage due to organic mercury exposure may be profound, permanent, and is generally resistant to treatment with chelating agents. Prevention of exposure to organic mercury is the most important aspect of management [<a href="#rid5">5,50</a>].</p><p>We do not use chelating agents for patients with toxic exposure to organic mercury, although the use of chelating agents is controversial among such patients. Central nervous system toxicity due to exposure to organic mercury is usually resistant to treatment with chelation. Furthermore, chelation with <a class="drug drug_general" data-topicid="9367" href="/z/d/drug information/9367.html" rel="external">dimercaprol</a> (British anti-Lewisite [BAL]) should not be used in organic mercury exposure, because it increases the mobilization of mercury to the brain. Treatment with oral <a class="drug drug_general" data-topicid="9102" href="/z/d/drug information/9102.html" rel="external">dimercaptosuccinic acid</a> (DMSA) is unlikely to reverse neurologic damage [<a href="#rid5">5,50</a>].</p><p class="headingAnchor" id="H1856611254"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110749.html" rel="external">"Society guideline links: Chronic kidney disease in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/112690.html" rel="external">"Society guideline links: Lead and other heavy metal poisoning"</a>.)</p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Different forms of mercury</strong> – Mercury exists in elemental, inorganic, and organic forms, all of which may be toxic. The toxic manifestation depends on the form of exposure. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Elemental mercury toxicity</strong> – Acute inhalation of high levels of elemental mercury vapor predominantly causes interstitial pneumonitis. Chronic exposure to lower concentrations of elemental mercury vapors results in predominantly nervous system effects that may be severe and irreversible. The diagnosis of elemental mercury toxicity is confirmed by measuring mercury in blood and/or 24-hour urine. Whole-blood mercury should be measured in the unstable patient who has suspected acute elemental mercury toxicity. Twenty-four-hour urine mercury measurement is the preferred test to assess toxicity in patients who have suspected stable and chronic exposure to elemental mercury. (See <a class="local">'Elemental mercury toxicity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inorganic mercury toxicity</strong> – The acute ingestion of inorganic mercury in the form of mercury salts may cause severe abdominal pain accompanied by a hemorrhagic gastroenteritis and severe volume depletion within several hours of ingestion. Ultimately, death may occur from cardiovascular collapse and shock. Chronic exposure to lower concentrations of inorganic mercury salts may cause neurologic symptoms and a nephrotic syndrome, typically of minimal change or membranous type. The diagnosis of inorganic mercury toxicity is confirmed by measuring mercury in blood and/or 24-hour urine. Whole-blood mercury should be measured in the unstable patient who has suspected acute inorganic mercury toxicity. Twenty-four-hour urine mercury measurement is the preferred test to assess toxicity in patients who have suspected stable and chronic exposure to inorganic mercury. (See <a class="local">'Inorganic mercury salts toxicity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Organic mercury toxicity</strong> – Organic mercury exposure causes acute gastrointestinal and respiratory symptoms, followed by neurologic symptoms. The toxicity of prenatal organic mercury to the fetus can be profound and causes irreversible neurologic damage. The preferred test for determining toxicity from organic mercury is a whole-blood mercury level. (See <a class="local">'Organic mercury toxicity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of elemental and inorganic mercury toxicity</strong> – The management of mercury toxicity begins with removing the patient from the source of exposure. Other measures depend on the form and severity of exposure  (<a class="graphic graphic_algorithm graphicRef105829" href="/z/d/graphic/105829.html" rel="external">algorithm 1</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Supportive care</strong> – All patients should receive initial supportive care measures.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with <strong>acute elemental mercury vapor exposure</strong> who present with respiratory symptoms should receive supportive care including supplemental oxygen, bronchodilators, and imaging to evaluate for pneumonitis or pulmonary edema. (See <a class="local">'General measures and supportive care'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with <strong>acute inorganic mercury ingestion</strong> require aggressive fluid resuscitation, given the high risk of severe gastrointestinal symptoms leading to shock and kidney failure. All patients should be monitored for electrolyte abnormalities or kidney injury from fluid and electrolyte losses. (See <a class="local">'General measures and supportive care'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chelation therapy</strong> – Among symptomatic patients with <strong>elemental</strong> or <strong>inorganic mercury exposure</strong> who have urine or whole-blood mercury concentrations of 100 mcg/L or greater, we recommend chelation treatment (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). The preferred agents are <a class="drug drug_general" data-topicid="9102" href="/z/d/drug information/9102.html" rel="external">dimercaptosuccinic acid</a> (DMSA; if in the United States) or 2,3 dimercaptopropane-1-sulfonate (DMPS; if outside the United States).(See <a class="local">'Chelator treatment'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>If DMSA is used, a preferred regimen is 10 mg/kg orally three times daily for five days, then twice daily for 14 days.</p><p></p><p class="bulletIndent3">If patients are unable to tolerate oral intake, <a class="drug drug_general" data-topicid="9367" href="/z/d/drug information/9367.html" rel="external">dimercaprol</a> (British anti-Lewisite [BAL]) is administered by deep intramuscular (IM) injection, 5 mg/kg/dose every four hours for 48 hours, then 2.5 mg/kg/dose every six hours for 48 hours, then 2.5 mg/kg/dose every 12 hours for seven days. Patients initially treated with BAL who subsequently are able to tolerate oral intake may be transitioned to DMSA treatment.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>If DMPS is used, a preferred regimen is 250 mg IM or intravenous (IV) every four hours on day 1, 250 mg IM or IV every six hours on day 2, and 250 mg IM or IV every six to eight hours for days 3 to 5. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of organic mercury toxicity</strong> – There is no effective treatment for toxic exposure to organic mercury. All patients with potential organic mercury toxicity should cease all exposure to mercury. Symptoms are generally resistant to treatment with chelators  (<a class="graphic graphic_algorithm graphicRef105829" href="/z/d/graphic/105829.html" rel="external">algorithm 1</a>). <a class="drug drug_general" data-topicid="9367" href="/z/d/drug information/9367.html" rel="external">Dimercaprol</a> (BAL) should <strong>NOT</strong> be used, because it increases the mobilization of mercury to the brain. Treatment with oral DMSA is unlikely to reverse neurologic damage. (See <a class="local">'Treatment'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">United Nations Environment Programme. Mercury in products and wastes. 2008. http://www.unep.org/hazardoussubstances/Portals/9/Mercury/AwarenessPack/English/UNEP_Mod1_UK_Web.pdf (Accessed on May 21, 2015).</li><li><a class="nounderline abstract_t">Magos L. Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products. J Appl Toxicol 2001; 21:1.</a></li><li><a class="nounderline abstract_t">Clarkson TW. The three modern faces of mercury. Environ Health Perspect 2002; 110 Suppl 1:11.</a></li><li class="breakAll">Fowler BA, Zalups RK. Mercury. In: Handbook on the Toxicology of Metals, Fifth ed, Nordberg GF, Costa M (Eds), Academic Press, 2022. p.539.</li><li class="breakAll">Sue Y. Mercury. In: Goldfrank's Toxicologic Emergencies, 10th ed, Hoffman RS, Howland M, Lewin NA, et al (Eds), McGraw-Hill, New York 2015.</li><li class="breakAll">WHO. Inorganic mercury. Environmental Health Criteria 118. World Health Organization, Geneva, 1991.</li><li><a class="nounderline abstract_t">Clarkson TW, Magos L, Myers GJ. The toxicology of mercury--current exposures and clinical manifestations. N Engl J Med 2003; 349:1731.</a></li><li><a class="nounderline abstract_t">Pandalai SL, Morgan BW. Case files of the Emory University Medical Toxicology Fellowship: inhalational mercury toxicity from a traditional Vietnamese product. J Med Toxicol 2011; 7:295.</a></li><li class="breakAll">Toxicological profile for mercury. Agency for Toxic Substances Disease Registry, Atlanta, 1999.</li><li><a class="nounderline abstract_t">Pickering TG. What will replace the mercury sphygmomanometer? Blood Press Monit 2003; 8:23.</a></li><li><a class="nounderline abstract_t">Salthammer T, Uhde E, Omelan A, et al. Estimating human indoor exposure to elemental mercury from broken compact fluorescent lamps (CFLs). Indoor Air 2012; 22:289.</a></li><li><a class="nounderline abstract_t">Wilson E, Lafferty JS, Thiboldeaux R, et al. Occupational Mercury Exposure at a Fluorescent Lamp Recycling Facility - Wisconsin, 2017. MMWR Morb Mortal Wkly Rep 2018; 67:763.</a></li><li><a class="nounderline abstract_t">Darvishi E, Assari MJ, Farhadian M, et al. Occupational exposure to mercury vapor in a compact fluorescent lamp factory: Evaluation of personal, ambient air, and biological monitoring. Toxicol Ind Health 2019; 35:304.</a></li><li><a class="nounderline abstract_t">Seccatore J, Veiga M, Origliasso C, et al. An estimation of the artisanal small-scale production of gold in the world. Sci Total Environ 2014; 496:662.</a></li><li><a class="nounderline abstract_t">Malm O. Gold mining as a source of mercury exposure in the Brazilian Amazon. Environ Res 1998; 77:73.</a></li><li><a class="nounderline abstract_t">Esdaile LJ, Chalker JM. The Mercury Problem in Artisanal and Small-Scale Gold Mining. Chemistry 2018; 24:6905.</a></li><li><a class="nounderline abstract_t">Noble MJ, Decker SL, Horowitz BZ. Inhalational mercury toxicity from artisanal gold extraction reported to the Oregon poison center, 2002-2015. Clin Toxicol (Phila) 2016; 54:847.</a></li><li><a class="nounderline abstract_t">Koirala S, Leinenkugel K. Notes from the Field: Acute Mercury Poisoning After Home Gold and Silver Smelting--Iowa, 2014. MMWR Morb Mortal Wkly Rep 2015; 64:1365.</a></li><li><a class="nounderline abstract_t">Sällsten G, Barregård L, Osterberg T. [Tooth grinding among wearers of amalgam fillings--a cause of high mercury release?]. Lakartidningen 1991; 88:232.</a></li><li class="breakAll">Agency for Toxic Substances and Disease Registry http://www.atsdr.cdc.gov/csem/csem.html (Accessed on October 01, 2015).</li><li><a class="nounderline abstract_t">Mackert JR Jr, Berglund A. Mercury exposure from dental amalgam fillings: absorbed dose and the potential for adverse health effects. Crit Rev Oral Biol Med 1997; 8:410.</a></li><li><a class="nounderline abstract_t">Spencer AJ. Dental amalgam and mercury in dentistry. Aust Dent J 2000; 45:224.</a></li><li><a class="nounderline abstract_t">Bates MN. Mercury amalgam dental fillings: an epidemiologic assessment. Int J Hyg Environ Health 2006; 209:309.</a></li><li><a class="nounderline abstract_t">Scientific Committee SCHER, Linders J, Janssen C, et al. Opinion on environmental risks and indirect health effects of mercury from dental amalgam. Regul Toxicol Pharmacol 2015; 72:85.</a></li><li><a class="nounderline abstract_t">Brownawell AM, Berent S, Brent RL, et al. The potential adverse health effects of dental amalgam. Toxicol Rev 2005; 24:1.</a></li><li><a class="nounderline abstract_t">Sandborgh-Englund G, Nygren AT, Ekstrand J, Elinder CG. No evidence of renal toxicity from amalgam fillings. Am J Physiol 1996; 271:R941.</a></li><li><a class="nounderline abstract_t">Bellinger DC, Trachtenberg F, Barregard L, et al. Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA 2006; 295:1775.</a></li><li><a class="nounderline abstract_t">Barregard L, Trachtenberg F, McKinlay S. Renal effects of dental amalgam in children: the New England children's amalgam trial. Environ Health Perspect 2008; 116:394.</a></li><li><a class="nounderline abstract_t">Kolipinski M, Subramanian M, Kristen K, et al. Sources and Toxicity of Mercury in the San Francisco Bay Area, Spanning California and Beyond. J Environ Public Health 2020; 2020:8184614.</a></li><li><a class="nounderline abstract_t">Vahabzadeh M, Balali-Mood M. Occupational Metallic Mercury Poisoning in Gilders. Int J Occup Environ Med 2016; 7:116.</a></li><li><a class="nounderline abstract_t">Ramli FF. Clinical management of chronic mercury intoxication secondary to skin lightening products: A proposed algorithm. Bosn J Basic Med Sci 2021; 21:261.</a></li><li><a class="nounderline abstract_t">Chan TY. Inorganic mercury poisoning associated with skin-lightening cosmetic products. Clin Toxicol (Phila) 2011; 49:886.</a></li><li><a class="nounderline abstract_t">Sällsten G, Barregård L, Järvholm B. Mercury in the Swedish chloralkali industry--an evaluation of the exposure and preventive measures over 40 years. Ann Occup Hyg 1990; 34:205.</a></li><li><a class="nounderline abstract_t">Bluhm RE, Bobbitt RG, Welch LW, et al. Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part I: History, neuropsychological findings and chelator effects. Hum Exp Toxicol 1992; 11:201.</a></li><li><a class="nounderline abstract_t">Bluhm RE, Breyer JA, Bobbitt RG, et al. Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part II: Hyperchloraemia and genitourinary symptoms. Hum Exp Toxicol 1992; 11:211.</a></li><li class="breakAll">United States Department of Labor Occupational Safety &amp; Health Administration. Mercury. https://www.osha.gov/SLTC/mercury/standards.html (Accessed on May 22, 2015).</li><li class="breakAll">Elinder CG, Friberg L, Nordberg GF, et al. Biological monitoring of metals. Chemical Safety Monographs. International Program on Chemical Safety. WHO/EHG/94.2 1994; 1.</li><li><a class="nounderline abstract_t">Aaseth J, Hilt B, Bjørklund G. Mercury exposure and health impacts in dental personnel. Environ Res 2018; 164:65.</a></li><li class="breakAll">United States Department of Labor, Occupational Safety and Health Administration. Safety and Health Topics: Mercury. https://www.osha.gov/SLTC/mercury/index.html (Accessed on March 08, 2018).</li><li class="breakAll">United States Department of Labor, Occupational Safety and Health Administration. Protecting workers from mercury exposure while crushing and recycling fluorescent bulbs. https://www.osha.gov/Publications/mercuryexposure_fluorescentbulbs_factsheet.html (Accessed on March 08, 2018).</li><li class="breakAll">Schutte NP, Knight AL, Jahn O. Mercury and its compounds. In: Occupational Medicine, 3rd ed, Zenz C, Dickerson OB, Horovath EP (Eds), Mosby-Year Book, St. Louis 1994. p.549.</li><li><a class="nounderline abstract_t">Kanluen S, Gottlieb CA. A clinical pathologic study of four adult cases of acute mercury inhalation toxicity. Arch Pathol Lab Med 1991; 115:56.</a></li><li><a class="nounderline abstract_t">Rowens B, Guerrero-Betancourt D, Gottlieb CA, et al. Respiratory failure and death following acute inhalation of mercury vapor. A clinical and histologic perspective. Chest 1991; 99:185.</a></li><li><a class="nounderline abstract_t">Asano S, Eto K, Kurisaki E, et al. Review article: acute inorganic mercury vapor inhalation poisoning. Pathol Int 2000; 50:169.</a></li><li><a class="nounderline abstract_t">Crump KS, Kjellström T, Shipp AM, et al. Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Anal 1998; 18:701.</a></li><li><a class="nounderline abstract_t">Debes F, Budtz-Jørgensen E, Weihe P, et al. Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol Teratol 2006; 28:536.</a></li><li><a class="nounderline abstract_t">Aymaz S, Gross O, Krakamp B, et al. Membranous nephropathy from exposure to mercury in the fluorescent-tube-recycling industry. Nephrol Dial Transplant 2001; 16:2253.</a></li><li><a class="nounderline abstract_t">Onwuzuligbo O, Hendricks AR, Hassler J, et al. Mercury Intoxication as a Rare Cause of Membranous Nephropathy in a Child. Am J Kidney Dis 2018; 72:601.</a></li><li><a class="nounderline abstract_t">Yawei S, Jianhai L, Junxiu Z, et al. Epidemiology, clinical presentation, treatment, and follow-up of chronic mercury poisoning in China: a retrospective analysis. BMC Pharmacol Toxicol 2021; 22:25.</a></li><li class="breakAll">Agocs M. Case studies in environmental medicine: Mercury toxicity. Agency for Toxic Substances and Disease Registry; US Department of Health &amp; Human Services, 1992.</li><li><a class="nounderline abstract_t">Clarkson TW. Mercury--an element of mystery. N Engl J Med 1990; 323:1137.</a></li><li><a class="nounderline abstract_t">Tunnessen WW Jr, McMahon KJ, Baser M. Acrodynia: exposure to mercury from fluorescent light bulbs. Pediatrics 1987; 79:786.</a></li><li><a class="nounderline abstract_t">WARKANY J, HUBBARD DM. Adverse mercurial reactions in the form of acrodynia and related conditions. AMA Am J Dis Child 1951; 81:335.</a></li><li><a class="nounderline abstract_t">Tewell M, Spoto S, Wiese M, et al. Mercury Poisoning at a Home Day Care Center - Hillsborough County, Florida, 2015. MMWR Morb Mortal Wkly Rep 2017; 66:433.</a></li><li><a class="nounderline abstract_t">Lai O, Parsi KK, Wu D, et al. Mercury toxicity presenting as acrodynia and a papulovesicular eruption in a 5-year-old girl. Dermatol Online J 2016; 22.</a></li><li><a class="nounderline abstract_t">Roels H, Gennart JP, Lauwerys R, et al. Surveillance of workers exposed to mercury vapour:validation of a previously proposed biological threshold limit value for mercury concentration in urine. Am J Ind Med 1985; 7:45.</a></li><li><a class="nounderline abstract_t">Stonard MD, Chater BV, Duffield DP, et al. An evaluation of renal function in workers occupationally exposed to mercury vapour. Int Arch Occup Environ Health 1983; 52:177.</a></li><li><a class="nounderline abstract_t">Barregård L, Hultberg B, Schütz A, Sällsten G. Enzymuria in workers exposed to inorganic mercury. Int Arch Occup Environ Health 1988; 61:65.</a></li><li><a class="nounderline abstract_t">Langworth S, Elinder CG, Sundquist KG, Vesterberg O. Renal and immunological effects of occupational exposure to inorganic mercury. Br J Ind Med 1992; 49:394.</a></li><li><a class="nounderline abstract_t">Van Vleet TR, Schnellmann RG. Toxic nephropathy: environmental chemicals. Semin Nephrol 2003; 23:500.</a></li><li><a class="nounderline abstract_t">Frumkin H, Letz R, Williams PL, et al. Health effects of long-term mercury exposure among chloralkali plant workers. Am J Ind Med 2001; 39:1.</a></li><li><a class="nounderline abstract_t">Zhang J. Clinical observations in ethyl mercury chloride poisoning. Am J Ind Med 1984; 5:251.</a></li><li><a class="nounderline abstract_t">Bradberry SM, Sheehan TM, Barraclough CR, Vale JA. DMPS can reverse the features of severe mercury vapor-induced neurological damage. Clin Toxicol (Phila) 2009; 47:894.</a></li><li><a class="nounderline abstract_t">Böse-O'Reilly S, Drasch G, Beinhoff C, et al. The Mt. Diwata study on the Philippines 2000-treatment of mercury intoxicated inhabitants of a gold mining area with DMPS (2,3-dimercapto-1-propane-sulfonic acid, Dimaval). Sci Total Environ 2003; 307:71.</a></li><li><a class="nounderline abstract_t">Sällsten G, Barregård L, Schütz A. Clearance half life of mercury in urine after the cessation of long term occupational exposure: influence of a chelating agent (DMPS) on excretion of mercury in urine. Occup Environ Med 1994; 51:337.</a></li><li><a class="nounderline abstract_t">Calabrese EJ, Iavicoli I, Calabrese V, et al. Elemental mercury neurotoxicity and clinical recovery of function: A review of findings, and implications for occupational health. Environ Res 2018; 163:134.</a></li><li><a class="nounderline abstract_t">Sauder P, Livardjani F, Jaeger A, et al. Acute mercury chloride intoxication. Effects of hemodialysis and plasma exchange on mercury kinetic. J Toxicol Clin Toxicol 1988; 26:189.</a></li><li><a class="nounderline abstract_t">BURSTON J, DARMADY EM, STRANACK F. Nephrosis dur to mercurial diuretics. Br Med J 1958; 1:1277.</a></li><li><a class="nounderline abstract_t">RIDDLE M, GARDNER F, BESWICK I, FILSHIE I. The nephrotic syndrome complicating mercurial diuretic therapy. Br Med J 1958; 1:1274.</a></li><li><a class="nounderline abstract_t">PREEDY JR, RUSSELL DS. Acute salt depletion associated with the nephrotic syndrome developing during treatment with a mercurial diuretic. Lancet 1953; 265:1181.</a></li><li class="breakAll">Magos L. Mercury. In: Handbook on Toxicity of Inorganic Compounds, Seller HG (Ed), Marcel Dekker, New York 1988. p.419.</li><li><a class="nounderline abstract_t">Oliveira DB, Foster G, Savill J, et al. Membranous nephropathy caused by mercury-containing skin lightening cream. Postgrad Med J 1987; 63:303.</a></li><li><a class="nounderline abstract_t">Li SJ, Zhang SH, Chen HP, et al. Mercury-induced membranous nephropathy: clinical and pathological features. Clin J Am Soc Nephrol 2010; 5:439.</a></li><li><a class="nounderline abstract_t">Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA 2008; 300:915.</a></li><li><a class="nounderline abstract_t">Miller S, Pallan S, Gangji AS, et al. Mercury-associated nephrotic syndrome: a case report and systematic review of the literature. Am J Kidney Dis 2013; 62:135.</a></li><li><a class="nounderline abstract_t">Tang HL, Chu KH, Mak YF, et al. Minimal change disease following exposure to mercury-containing skin lightening cream. Hong Kong Med J 2006; 12:316.</a></li><li><a class="nounderline abstract_t">Sunderman FW. Perils of mercury. Ann Clin Lab Sci 1988; 18:89.</a></li><li><a class="nounderline abstract_t">Black J. The puzzle of pink disease. J R Soc Med 1999; 92:478.</a></li><li><a class="nounderline abstract_t">Dally A. The rise and fall of pink disease. Soc Hist Med 1997; 10:291.</a></li><li><a class="nounderline abstract_t">Gao Z, Wu N, Du X, et al. Toxic Nephropathy Secondary to Chronic Mercury Poisoning: Clinical Characteristics and Outcomes. Kidney Int Rep 2022; 7:1189.</a></li><li><a class="nounderline abstract_t">CAMERON JS, TROUNCE JR. MEMBRANOUS GLOMERULONEPHRITIS AND THE NEPHROTIC SYNDROME APPEARING DURING MERSALYL THERAPY. Guys Hosp Rep 1965; 114:101.</a></li><li class="breakAll">Schnellmann R. Toxic responses of the kidney. In: Casarett and Doull's Toxicology. The Basic Sciences of Poisons, 6th ed, McGraw-Hill, New York 2001. p.491.</li><li><a class="nounderline abstract_t">BECKER CG, BECKER EL, MAHER JF, SCHREINER GE. Nephrotic syndrome after contact with mercury. A report of five cases, three after the use of ammoniated mercury ointment. Arch Intern Med 1962; 110:178.</a></li><li><a class="nounderline abstract_t">MUNCK O, NISSEN NI. Development of nephrotic syndrome during treatment with mercurial diuretics. Acta Med Scand 1956; 153:307.</a></li><li><a class="nounderline abstract_t">Gao H, Liu G, He Y, Chen J. Nephrotic syndrome of minimal change disease following exposure to mercury-containing skin lightening cream: A case report and literature review. Clin Nephrol 2022; 98:107.</a></li><li><a class="nounderline abstract_t">WILLIAMS NE, BRIDGE HG. Nephrotic syndrome after the application of mercury ointment. Lancet 1958; 2:602.</a></li><li><a class="nounderline abstract_t">WILSON VK, THOMSON ML, HOLZEL A. Mercury nephrosis in young children, with special reference to teething powders containing mercury. Br Med J 1952; 1:358.</a></li><li><a class="nounderline abstract_t">Barr RD, Rees PH, Cordy PE, et al. Nephrotic syndrome in adult Africans in Nairobi. Br Med J 1972; 2:131.</a></li><li><a class="nounderline abstract_t">Agner E, Jans H. Mercury poisoning and nephrotic syndrome in two young siblings. Lancet 1978; 2:951.</a></li><li><a class="nounderline abstract_t">FRIBERG L, HAMMARSTROM S, NYSTROM A. Kidney injury after exposure to inorganic mercury. AMA Arch Ind Hyg Occup Med 1953; 8:149.</a></li><li><a class="nounderline abstract_t">KAZANTZIS G, SCHILLER KF, ASSCHER AW, DREW RG. Albuminuria and the nephrotic syndrome following exposure to mercury and its compounds. Q J Med 1962; 31:403.</a></li><li><a class="nounderline abstract_t">Qin AB, Su T, Wang SX, et al. Mercury-associated glomerulonephritis: a retrospective study of 35 cases in a single Chinese center. BMC Nephrol 2019; 20:228.</a></li><li class="breakAll">Fowler BA, Whittaker MH, Elinder CG. Mercury-induced renal effects. In: Clinical Nephrotoxins. Renal Injury from Drugs and Chemicals, 3rd ed, De Broe M, Porter GA (Eds), Springer, New York 2008. p.811.</li><li><a class="nounderline abstract_t">Winship KA. Organic mercury compounds and their toxicity. Adverse Drug React Acute Poisoning Rev 1986; 5:141.</a></li><li><a class="nounderline abstract_t">Inouye M, Kajiwara Y. Developmental disturbances of the fetal brain in guinea-pigs caused by methylmercury. Arch Toxicol 1988; 62:15.</a></li><li><a class="nounderline abstract_t">Katz SA, Katz RB. Use of hair analysis for evaluating mercury intoxication of the human body: a review. J Appl Toxicol 1992; 12:79.</a></li><li><a class="nounderline abstract_t">Nierenberg DW, Nordgren RE, Chang MB, et al. Delayed cerebellar disease and death after accidental exposure to dimethylmercury. N Engl J Med 1998; 338:1672.</a></li><li><a class="nounderline abstract_t">Kulig K. A tragic reminder about organic mercury. N Engl J Med 1998; 338:1692.</a></li><li><a class="nounderline abstract_t">Kessler R. The Minamata Convention on Mercury: a first step toward protecting future generations. Environ Health Perspect 2013; 121:A304.</a></li><li><a class="nounderline abstract_t">Eto K, Tokunaga H, Nagashima K, Takeuchi T. An autopsy case of minamata disease (methylmercury poisoning)--pathological viewpoints of peripheral nerves. Toxicol Pathol 2002; 30:714.</a></li><li><a class="nounderline abstract_t">Amin-zaki L, Majeed MA, Clarkson TW, Greenwood MR. Methylmercury poisoning in Iraqi children: clinical observations over two years. Br Med J 1978; 1:613.</a></li><li><a class="nounderline abstract_t">Andrews N, Miller E, Grant A, et al. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association. Pediatrics 2004; 114:584.</a></li><li><a class="nounderline abstract_t">Madsen KM, Lauritsen MB, Pedersen CB, et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics 2003; 112:604.</a></li><li><a class="nounderline abstract_t">Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 2004; 114:793.</a></li><li class="breakAll">Global Alliance for Vaccines and Immunisation. Report to the GAVI Alliance Board Report of the Chief Executive Officer. 2012.</li><li class="breakAll">WHO. Methylmercury. Environmental Health Criteria 101. World Health Organization, Geneva 1990.</li><li><a class="nounderline abstract_t">Yokoo EM, Valente JG, Grattan L, et al. Low level methylmercury exposure affects neuropsychological function in adults. Environ Health 2003; 2:8.</a></li><li><a class="nounderline abstract_t">Ronchetti R, Zuurbier M, Jesenak M, et al. Children's health and mercury exposure. Acta Paediatr Suppl 2006; 95:36.</a></li></ol></div><div id="topicVersionRevision">Topic 7179 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="http://www.unep.org/hazardoussubstances/Portals/9/Mercury/AwarenessPack/English/UNEP_Mod1_UK_Web.pdf" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : United Nations Environment Programme. Mercury in products and wastes. 2008. http://www.unep.org/hazardoussubstances/Portals/9/Mercury/AwarenessPack/English/UNEP_Mod1_UK_Web.pdf (Accessed on May 21, 2015).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11180274" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834460" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The three modern faces of mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834460" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The three modern faces of mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834460" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The three modern faces of mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834460" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The three modern faces of mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14585942" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The toxicology of mercury--current exposures and clinical manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22072090" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Case files of the Emory University Medical Toxicology Fellowship: inhalational mercury toxicity from a traditional Vietnamese product.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22072090" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Case files of the Emory University Medical Toxicology Fellowship: inhalational mercury toxicity from a traditional Vietnamese product.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12604932" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : What will replace the mercury sphygmomanometer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22188528" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Estimating human indoor exposure to elemental mercury from broken compact fluorescent lamps (CFLs).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30001557" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Occupational Mercury Exposure at a Fluorescent Lamp Recycling Facility - Wisconsin, 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30917767" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Occupational exposure to mercury vapor in a compact fluorescent lamp factory: Evaluation of personal, ambient air, and biological monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24867677" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : An estimation of the artisanal small-scale production of gold in the world.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9600798" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Gold mining as a source of mercury exposure in the Brazilian Amazon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29314284" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The Mercury Problem in Artisanal and Small-Scale Gold Mining.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27338817" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Inhalational mercury toxicity from artisanal gold extraction reported to the Oregon poison center, 2002-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26678598" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Notes from the Field: Acute Mercury Poisoning After Home Gold and Silver Smelting--Iowa, 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1994170" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : [Tooth grinding among wearers of amalgam fillings--a cause of high mercury release?].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1994170" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : [Tooth grinding among wearers of amalgam fillings--a cause of high mercury release?].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9391753" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Mercury exposure from dental amalgam fillings: absorbed dose and the potential for adverse health effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11225523" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Dental amalgam and mercury in dentistry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16448848" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Mercury amalgam dental fillings: an epidemiologic assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25817735" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Opinion on environmental risks and indirect health effects of mercury from dental amalgam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16042501" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The potential adverse health effects of dental amalgam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8897985" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : No evidence of renal toxicity from amalgam fillings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16622139" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18335109" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Renal effects of dental amalgam in children: the New England children's amalgam trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33014081" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sources and Toxicity of Mercury in the San Francisco Bay Area, Spanning California and Beyond.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27112720" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Occupational Metallic Mercury Poisoning in Gilders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32415819" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Clinical management of chronic mercury intoxication secondary to skin lightening products: A proposed algorithm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22070559" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Inorganic mercury poisoning associated with skin-lightening cosmetic products.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2400180" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Mercury in the Swedish chloralkali industry--an evaluation of the exposure and preventive measures over 40 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1352115" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part I: History, neuropsychological findings and chelator effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1352116" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part II: Hyperchloraemia and genitourinary symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1352116" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part II: Hyperchloraemia and genitourinary symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1352116" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part II: Hyperchloraemia and genitourinary symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29482185" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Mercury exposure and health impacts in dental personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29482185" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Mercury exposure and health impacts in dental personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29482185" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Mercury exposure and health impacts in dental personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29482185" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Mercury exposure and health impacts in dental personnel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1987914" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A clinical pathologic study of four adult cases of acute mercury inhalation toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1984951" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Respiratory failure and death following acute inhalation of mercury vapor. A clinical and histologic perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10792779" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Review article: acute inorganic mercury vapor inhalation poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9972579" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17067778" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11682678" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Membranous nephropathy from exposure to mercury in the fluorescent-tube-recycling industry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30041877" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Mercury Intoxication as a Rare Cause of Membranous Nephropathy in a Child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33941274" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Epidemiology, clinical presentation, treatment, and follow-up of chronic mercury poisoning in China: a retrospective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33941274" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Epidemiology, clinical presentation, treatment, and follow-up of chronic mercury poisoning in China: a retrospective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2215583" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Mercury--an element of mystery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3575038" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Acrodynia: exposure to mercury from fluorescent light bulbs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14810170" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Adverse mercurial reactions in the form of acrodynia and related conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28472024" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Mercury Poisoning at a Home Day Care Center - Hillsborough County, Florida, 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27136627" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Mercury toxicity presenting as acrodynia and a papulovesicular eruption in a 5-year-old girl.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3871586" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Surveillance of workers exposed to mercury vapour:validation of a previously proposed biological threshold limit value for mercury concentration in urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6354940" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : An evaluation of renal function in workers occupationally exposed to mercury vapour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3264272" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Enzymuria in workers exposed to inorganic mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1606025" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Renal and immunological effects of occupational exposure to inorganic mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13680539" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Toxic nephropathy: environmental chemicals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11148011" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Health effects of long-term mercury exposure among chloralkali plant workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6422751" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Clinical observations in ethyl mercury chloride poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19852623" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : DMPS can reverse the features of severe mercury vapor-induced neurological damage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12711426" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The Mt. Diwata study on the Philippines 2000-treatment of mercury intoxicated inhabitants of a gold mining area with DMPS (2,3-dimercapto-1-propane-sulfonic acid, Dimaval).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8199685" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Clearance half life of mercury in urine after the cessation of long term occupational exposure: influence of a chelating agent (DMPS) on excretion of mercury in urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29438899" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Elemental mercury neurotoxicity and clinical recovery of function: A review of findings, and implications for occupational health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3418774" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Acute mercury chloride intoxication. Effects of hemodialysis and plasma exchange on mercury kinetic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13536477" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Nephrosis dur to mercurial diuretics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13536476" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The nephrotic syndrome complicating mercurial diuretic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13110097" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Acute salt depletion associated with the nephrotic syndrome developing during treatment with a mercurial diuretic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13110097" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Acute salt depletion associated with the nephrotic syndrome developing during treatment with a mercurial diuretic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3684841" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Membranous nephropathy caused by mercury-containing skin lightening cream.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20089494" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Mercury-induced membranous nephropathy: clinical and pathological features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18728265" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23602193" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Mercury-associated nephrotic syndrome: a case report and systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16912361" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Minimal change disease following exposure to mercury-containing skin lightening cream.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3289472" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Perils of mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10645305" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The puzzle of pink disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11619497" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : The rise and fall of pink disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35694560" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Toxic Nephropathy Secondary to Chronic Mercury Poisoning: Clinical Characteristics and Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14319318" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : MEMBRANOUS GLOMERULONEPHRITIS AND THE NEPHROTIC SYNDROME APPEARING DURING MERSALYL THERAPY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14319318" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : MEMBRANOUS GLOMERULONEPHRITIS AND THE NEPHROTIC SYNDROME APPEARING DURING MERSALYL THERAPY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13866316" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Nephrotic syndrome after contact with mercury. A report of five cases, three after the use of ammoniated mercury ointment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13301462" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Development of nephrotic syndrome during treatment with mercurial diuretics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35603688" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Nephrotic syndrome of minimal change disease following exposure to mercury-containing skin lightening cream: A case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13588941" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Nephrotic syndrome after the application of mercury ointment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14896145" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Mercury nephrosis in young children, with special reference to teething powders containing mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4111681" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Nephrotic syndrome in adult Africans in Nairobi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/81974" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Mercury poisoning and nephrotic syndrome in two young siblings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13064872" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Kidney injury after exposure to inorganic mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14031598" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Albuminuria and the nephrotic syndrome following exposure to mercury and its compounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31221121" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Mercury-associated glomerulonephritis: a retrospective study of 35 cases in a single Chinese center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31221121" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Mercury-associated glomerulonephritis: a retrospective study of 35 cases in a single Chinese center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3538823" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Organic mercury compounds and their toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3190452" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Developmental disturbances of the fetal brain in guinea-pigs caused by methylmercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1556385" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Use of hair analysis for evaluating mercury intoxication of the human body: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9614258" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Delayed cerebellar disease and death after accidental exposure to dimethylmercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9614264" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : A tragic reminder about organic mercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24218675" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : The Minamata Convention on Mercury: a first step toward protecting future generations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12512873" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : An autopsy case of minamata disease (methylmercury poisoning)--pathological viewpoints of peripheral nerves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/630256" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Methylmercury poisoning in Iraqi children: clinical observations over two years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15342825" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12949291" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15342856" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15342856" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15342856" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12844364" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Low level methylmercury exposure affects neuropsychological function in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17000568" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Children's health and mercury exposure.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
